What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Surgery
- Disease
Carol A. Kauffman mostly deals with Internal medicine, Surgery, Mycosis, Intensive care medicine and Amphotericin B.
Her Surgery study incorporates themes from Antibiotics, Epidemiology, Clinical trial, Placebo and Mupirocin.
Her work deals with themes such as Pharmacotherapy, Itraconazole, Fluconazole and Chemotherapy, which intersect with Mycosis.
Her Intensive care medicine research incorporates themes from Cancer, Health care, MEDLINE, Guideline and Urinary system.
She combines subjects such as Gastroenterology, Aspergillosis and Pathology with her study of Amphotericin B.
Her Aspergillosis research includes themes of Organ transplantation and Voriconazole.
Her most cited work include:
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (3823 citations)
- Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. (2685 citations)
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (1406 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Internal medicine, Surgery, Microbiology, Intensive care medicine and Immunology.
The Internal medicine study combines topics in areas such as Gastroenterology, Fluconazole and Aspergillosis.
Her research integrates issues of Voriconazole and Aspergillus in her study of Aspergillosis.
In her research, Drug resistance is intimately related to Antibiotics, which falls under the overarching field of Surgery.
Her research in Intensive care medicine intersects with topics in Veterans Affairs, Clinical trial and MEDLINE.
Her studies in Mycosis integrate themes in fields like Pharmacotherapy and Chemotherapy.
She most often published in these fields:
- Internal medicine (39.36%)
- Surgery (27.93%)
- Microbiology (23.67%)
What were the highlights of her more recent work (between 2016-2021)?
- Internal medicine (39.36%)
- Aspergillosis (18.35%)
- Voriconazole (11.97%)
In recent papers she was focusing on the following fields of study:
Internal medicine, Aspergillosis, Voriconazole, Bronchoalveolar lavage and Dermatology are her primary areas of study.
Her studies deal with areas such as Gastroenterology and Bacteremia as well as Internal medicine.
Her Bacteremia research is multidisciplinary, incorporating perspectives in Surgery, Transplantation and Linezolid.
Her work carried out in the field of Voriconazole brings together such families of science as Itraconazole, Terbinafine, Fluconazole and Cohort.
Her studies link Amphotericin B with Itraconazole.
Within one scientific family, Carol A. Kauffman focuses on topics pertaining to Epidemiology under Histoplasmosis, and may sometimes address concerns connected to Paracoccidioidomycosis.
Between 2016 and 2021, her most popular works were:
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (454 citations)
- Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study. (63 citations)
- Manifestations and outcomes of nocardia infections: Comparison of immunocompromised and nonimmunocompromised adult patients. (46 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
Her main research concerns Internal medicine, Immunology, Aspergillosis, Mortality rate and Malignancy.
Carol A. Kauffman has researched Internal medicine in several fields, including Bacteremia and Inhalation.
Her Bacteremia study combines topics from a wide range of disciplines, such as Odds ratio, Hematopoietic stem cell transplantation, Surgery, Vancomycin-resistant Enterococcus and Linezolid.
Her research integrates issues of Wegener granulomatosis, Mycology culture, Aspergillus, Microbiology and Immunoenzyme techniques in her study of Aspergillosis.
Her Malignancy research includes elements of Epidemiology, Dermatology, Terbinafine, Voriconazole and Acute leukemia.
Voriconazole is closely attributed to Itraconazole in her study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
